Furthermore, in K562 tumor xenografts, co-injection of 6AzGal with the GLUT inhibitor14 significantly reduced the uptake signal in cancer cells (Fig. 4h and S6e), as observed in the in vitro GLUT specificity test (Fig. 3e). Here, SLC2A1 is linked to neoplasm.